Diabetic Osteomyelitis: Oral vs Intravenous Antibiotics at a Single Level 1 Academic Medical Trauma Center
Residual osteomyelitis is a frequent problem following surgical intervention for diabetic foot infection. The current Infectious Disease Society of America guidelines recommend 4-6 weeks of initial intravenous antibiotics for treatment of residual osteomyelitis. However, recent literature suggests oral antibiotic therapy is not inferior to intravenous therapy. The primary aim of this study was to evaluate treatment success in 128 patients receiving oral versus intravenous antibiotics for residual osteomyelitis in the diabetic foot after amputation at a Level 1 academic medical trauma center. (Source: Journal of Foot and Ankle Surgery)
Source: Journal of Foot and Ankle Surgery - April 6, 2024 Category: Orthopaedics Authors: Jennifer A. Kipp, Lindsay K. LeSavage, Joni K Evans, Travis A. Denmeade, Cody D. Blazek Tags: Original Research Source Type: research
Diabetic Osteomyelitis: Oral versus Intravenous Antibiotics at a Single Level 1 Academic Medical Trauma Center
Residual osteomyelitis is a frequent problem following surgical intervention for diabetic foot infection. The Infectious Disease Society of America guidelines recommend a prolonged course of antibiotics for treatment of residual osteomyelitis. Recent literature suggests oral antibiotic therapy is not inferior to IV therapy. The primary aim of this study was to evaluate treatment success in 128 patients receiving oral versus IV antibiotics for residual osteomyelitis in the diabetic foot after amputation at a Level 1 academic medical trauma center. (Source: Journal of Foot and Ankle Surgery)
Source: Journal of Foot and Ankle Surgery - April 6, 2024 Category: Orthopaedics Authors: Jennifer A. Kipp, Lindsay K. LeSavage, Joni K. Evans, Travis A. Denmeade, Cody D. Blazek Tags: Original Research Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Extravasation and infiltration: under-recognised complications of intravenous therapy
This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate.PMID:38578942 | DOI:10.12968/bjon.2024.33.7.S18 (Source: British Journal of Nursing)
Source: British Journal of Nursing - April 5, 2024 Category: Nursing Authors: Andrew Barton Source Type: research
Advancing Evidence-Based Peripheral Intravenous Catheter Securement
Intravenous therapy is a mainstay of care for hospitalized patients. In this issue of JAMA Pediatrics, Charters et al take on the essential investigation of how to improve peripheral intravenous catheter (PIVC) securement in children, given a failure rate of over 30% for PIVCs secured in the usual way. Not only could improving PIVC securement reduce premature removal and potential traumatic and painful reinsertions, but could result in fewer interruptions and delays to intravenous therapy, improving outcomes such as medication therapy effectiveness, and hospital length of stay. (Source: JAMA Pediatrics)
Source: JAMA Pediatrics - April 1, 2024 Category: Pediatrics Source Type: research
Elastomeric, fillable infusion pumps: an overview for clinical practice
This article provides an overview of the Surefuser+ elastomeric infusion pump, its features and mode of action and how it can be used in clinical practice.PMID:38530670 | DOI:10.12968/bjon.2023.32.Sup15.3 (Source: British Journal of Nursing)
Source: British Journal of Nursing - March 26, 2024 Category: Nursing Authors: Andrew Barton Ed Fisher Martin Rees-Milton Source Type: research
Elastomeric, fillable infusion pumps: an overview for clinical practice
This article provides an overview of the Surefuser+ elastomeric infusion pump, its features and mode of action and how it can be used in clinical practice.PMID:38530670 | DOI:10.12968/bjon.2023.32.Sup15.3 (Source: British Journal of Nursing)
Source: British Journal of Nursing - March 26, 2024 Category: Nursing Authors: Andrew Barton Ed Fisher Martin Rees-Milton Source Type: research
Elastomeric, fillable infusion pumps: an overview for clinical practice
This article provides an overview of the Surefuser+ elastomeric infusion pump, its features and mode of action and how it can be used in clinical practice.PMID:38530670 | DOI:10.12968/bjon.2023.32.Sup15.3 (Source: British Journal of Nursing)
Source: British Journal of Nursing - March 26, 2024 Category: Nursing Authors: Andrew Barton Ed Fisher Martin Rees-Milton Source Type: research
